Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

David A Norris

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-Dermatology
Phone303/724-4032
    Other Positions
    TitleChair
    InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
    DepartmentSOM-Dermatology


    Collapse Research 
    Collapse research activities and funding
    R13AR009431     (KULESZ-MARTIN, MOLLY F.)Mar 1, 1979 - May 31, 2021
    NIH/NIAMS
    Montagna Symposium on the Biology of Skin
    Role: Co-Principal Investigator

    R01AM026427     (NORRIS, DAVID A.)Jan 1, 1980 - Jun 30, 1986
    NIH/NIADDK
    CYTOTOXIC MECHANISMS IN CUTANEOUS DISEASE
    Role: Principal Investigator

    R01AR026427     (NORRIS, DAVID A.)Jan 1, 1980 - Aug 31, 2010
    NIH/NIAMS
    Cytotoxic Mechanisms in Cutaneous Disease
    Role: Principal Investigator

    T32AR007411     (ROOP, DENNIS)Jul 1, 1981 - Jun 30, 2020
    NIH/NIAMS
    Training in Immunodermatology
    Role: Co-Principal Investigator

    I01BX000141     (NORRIS, DAVID A.)Jul 1, 2009 - Dec 31, 2019
    VA
    Melanoma Resistance to Apoptosis: Mechanisms and Therapeutic Potential
    Role: Principal Investigator

    P30AR057212     (NORRIS, DAVID A.)Sep 28, 2009 - Jul 31, 2019
    NIH/NIAMS
    Molecular Analysis, Modeling and Correction of Skin Diseases Core Center
    Role: Principal Investigator

    I01BX002370     (NORRIS, DAVID A.)Apr 1, 2014 - Mar 31, 2018
    VA
    The Role of CtBP1 in UV-mediated Melanoma Carcinogenesis
    Role: Co-Principal Investigator

    R13AR067088     (NORRIS, DAVID A.)Sep 1, 2014 - Aug 31, 2015
    NIH/NIAMS
    Accelerating Autoimmune Treatments through Alopecia Areata Research
    Role: Principal Investigator

    R13AR071775     (NORRIS, DAVID A.)May 1, 2017 - Apr 30, 2018
    NIH/NIAMS
    2017 (IPCC) International Pigment Cell Conference
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Blevins MA, Zhang C, Zhang L, Li H, Li X, Norris DA, Huang M, Zhao R. CPP-E1A fusion peptides inhibit CtBP-mediated transcriptional repression. Mol Oncol. 2018 Jun 07. PMID: 29879296.
      View in: PubMed
    2. Del Rosario F, Farahi JM, Drendel J, Buntinx-Krieg T, Caravaglio J, Domozych R, Chapman S, Braunberger T, Dellavalle RP, Norris DA, Fathi R, Alkousakis T. Performance of a computer-aided digital dermoscopic image analyzer for melanoma detection in 1,076 pigmented skin lesion biopsies. J Am Acad Dermatol. 2018 May; 78(5):927-934.e6. PMID: 29678380.
      View in: PubMed
    3. Norris DA. Current State of Research and Summary of Preceding Summits. J Investig Dermatol Symp Proc. 2018 Jan; 19(1):S1-S2. PMID: 29273097.
      View in: PubMed
    4. Goldstein NB, Koster MI, Jones KL, Gao B, Hoaglin LG, Robinson SE, Wright MJ, Birlea SI, Luman A, Lambert KA, Shellman YG, Fujita M, Robinson WA, Roop DR, Norris DA, Birlea SA. Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the ├č-Catenin Pathway in the Hair Follicle Bulge Stem Cells. J Invest Dermatol. 2018 Mar; 138(3):657-668. PMID: 29054607.
      View in: PubMed
    5. Mukherjee N, Lu Y, Almeida A, Lambert K, Shiau CW, Su JC, Luo Y, Fujita M, Robinson WA, Robinson SE, Norris DA, Shellman YG. Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells. Oncotarget. 2017 Jul 18; 8(29):46801-46817. PMID: 27086916.
      View in: PubMed
    6. Mayer JE, Fathi R, Norris DA. Inaccuracies in SEER registry data on melanoma thickness. J Am Acad Dermatol. 2017 07; 77(1):e17. PMID: 28619572.
      View in: PubMed
    7. Birlea SA, Goldstein NB, Norris DA. Repigmentation through Melanocyte Regeneration in Vitiligo. Dermatol Clin. 2017 Apr; 35(2):205-218. PMID: 28317529.
      View in: PubMed
    8. Zhai Z, Liu W, Kaur M, Luo Y, Domenico J, Samson JM, Shellman YG, Norris DA, Dinarello CA, Spritz RA, Fujita M. NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma. Oncogene. 2017 07 06; 36(27):3820-3830. PMID: 28263976.
      View in: PubMed
    9. Birlea SA, Costin GE, Roop DR, Norris DA. Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization. Med Res Rev. 2017 07; 37(4):907-935. PMID: 28029168.
      View in: PubMed
    10. Mukherjee N, Almeida A, Partyka KA, Lu Y, Schwan JV, Lambert K, Rogers M, Robinson WA, Robinson SE, Applegate AJ, Amato CM, Luo Y, Fujita M, Norris DA, Shellman YG. Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments. Oncotarget. 2016 Dec 20; 7(51):84594-84607. PMID: 27829238.
      View in: PubMed
    11. Goldstein NB, Koster MI, Hoaglin LG, Wright MJ, Robinson SE, Robinson WA, Roop DR, Norris DA, Birlea SA. Isolating RNA from precursor and mature melanocytes from human vitiligo and normal skin using laser capture microdissection. Exp Dermatol. 2016 10; 25(10):805-11. PMID: 27193292.
      View in: PubMed
    12. Norris DA. Overview of AA and Research Progress: What Have We Learned and Where Are We Headed? J Investig Dermatol Symp Proc. 2015 Nov; 17(2):6-8. PMID: 26551935.
      View in: PubMed
    13. Kranz D, Ellison A, Frelinger JA, Mackay-Wiggan J, Norris DA. From Targets to Treatments: Bridging Autoimmune Research to Advance Understanding of Alopecia Areata. J Investig Dermatol Symp Proc. 2015 Nov; 17(2):1-5. PMID: 26551934.
      View in: PubMed
    14. Ryu S, Johnson A, Park Y, Kim B, Norris D, Armstrong CA, Song PI. The Alpha-Melanocyte-Stimulating Hormone Suppresses TLR2-Mediated Functional Responses through IRAK-M in Normal Human Keratinocytes. PLoS One. 2015; 10(8):e0136887. PMID: 26309029; PMCID: PMC4550463.
    15. Shellman YG, Lambert KA, Brauweiler A, Fain P, Spritz RA, Martini M, Janssen KP, Box NF, Terzian T, Rewers M, Horvath A, Stratakis CA, Robinson WA, Robinson SE, Norris DA, Artinger KB, Pacheco TR. SASH1 Is Involved in an Autosomal Dominant Lentiginous Phenotype. J Invest Dermatol. 2015 Dec; 135(12):3192-3194. PMID: 26203640; PMCID: PMC4648645.
    16. Mukherjee N, Schwan JV, Fujita M, Norris DA, Shellman YG. Alternative Treatments For Melanoma: Targeting BCL-2 Family Members to De-Bulk and Kill Cancer Stem Cells. J Invest Dermatol. 2015 Sep; 135(9):2155-2161. PMID: 25947358; PMCID: PMC4537369.
    17. Goldstein NB, Koster MI, Hoaglin LG, Spoelstra NS, Kechris KJ, Robinson SE, Robinson WA, Roop DR, Norris DA, Birlea SA. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors. J Invest Dermatol. 2015 Aug; 135(8):2068-2076. PMID: 25822579.
      View in: PubMed
    18. Mukherjee N, Reuland SN, Lu Y, Luo Y, Lambert K, Fujita M, Robinson WA, Robinson SE, Norris DA, Shellman YG. Combining a BCL2 inhibitor with the retinoid derivative fenretinide targets melanoma cells including melanoma initiating cells. J Invest Dermatol. 2015 Mar; 135(3):842-850. PMID: 25350317; PMCID: PMC4323853.
    19. Norris DA. Genes and immune response in alopecia areata: review of the alopecia areata research summit first day proceedings. J Investig Dermatol Symp Proc. 2013 Dec; 16(1):S10-2. PMID: 24326540.
      View in: PubMed
    20. Norris DA. Summary of the preceding three alopecia areata research summits: what's past is prologue. J Investig Dermatol Symp Proc. 2013 Dec; 16(1):S5-9. PMID: 24326556.
      View in: PubMed
    21. Duvic M, Christiano AM, Hordinsky MK, Norris DA, Price VH, Amos CI. The national alopecia areata registry-update. J Investig Dermatol Symp Proc. 2013 Dec; 16(1):S53. PMID: 24326558.
      View in: PubMed
    22. Shi Q, Duvic M, Osei JS, Hordinsky MK, Norris DA, Price VH, Amos CI, Christiano AM, Mendoza TR. Health-Related Quality of Life (HRQoL) in alopecia areata patients-a secondary analysis of the National Alopecia Areata Registry Data. J Investig Dermatol Symp Proc. 2013 Dec; 16(1):S49-50. PMID: 24326555.
      View in: PubMed
    23. Bennett PE, Bemis L, Norris DA, Shellman YG. miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma. Physiol Genomics. 2013 Nov 15; 45(22):1049-59. PMID: 24046283; PMCID: PMC4596730.
    24. Green JS, Norris DA, Wisell J. Novel cutaneous effects of combination chemotherapy with BRAF and MEK inhibitors: a report of two cases. Br J Dermatol. 2013 Jul; 169(1):172-6. PMID: 23413975.
      View in: PubMed
    25. Deng H, Liu J, Deng Y, Han G, Shellman YG, Robinson SE, Tentler JJ, Robinson WA, Norris DA, Wang XJ, Zhang Q. CtBP1 is expressed in melanoma and represses the transcription of p16INK4a and Brca1. J Invest Dermatol. 2013 May; 133(5):1294-301. PMID: 23303449; PMCID: PMC3711675.
    26. Edwards CK, Green JS, Volk HD, Schiff M, Kotzin BL, Mitsuya H, Kawaguchi T, Sakata KM, Cheronis J, Trollinger D, Bankaitis-Davis D, Dinarello CA, Norris DA, Bevilacqua MP, Fujita M, Burmester GR. Combined anti-tumor necrosis factor-a therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy alone. Front Immunol. 2012; 3:366. PMID: 23264777; PMCID: PMC3525111.
    27. Reuland SN, Smith SM, Bemis LT, Goldstein NB, Almeida AR, Partyka KA, Marquez VE, Zhang Q, Norris DA, Shellman YG. MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD). J Invest Dermatol. 2013 May; 133(5):1286-93. PMID: 23190898; PMCID: PMC3898712.
    28. Luo Y, Dallaglio K, Chen Y, Robinson WA, Robinson SE, McCarter MD, Wang J, Gonzalez R, Thompson DC, Norris DA, Roop DR, Vasiliou V, Fujita M. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells. 2012 Oct; 30(10):2100-13. PMID: 22887839; PMCID: PMC3448863.
    29. Liu W, Luo Y, Dunn JH, Norris DA, Dinarello CA, Fujita M. Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in tumorigenesis of human melanoma. J Invest Dermatol. 2013 Feb; 133(2):518-27. PMID: 22931929; PMCID: PMC3511638.
    30. Luo Y, Ellis LZ, Dallaglio K, Takeda M, Robinson WA, Robinson SE, Liu W, Lewis KD, McCarter MD, Gonzalez R, Norris DA, Roop DR, Spritz RA, Ahn NG, Fujita M. Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance. J Invest Dermatol. 2012 Oct; 132(10):2440-2450. PMID: 22622430; PMCID: PMC3434242.
    31. Smith SM, Wunder MB, Norris DA, Shellman YG. A simple protocol for using a LDH-based cytotoxicity assay to assess the effects of death and growth inhibition at the same time. PLoS One. 2011; 6(11):e26908. PMID: 22125603; PMCID: PMC3219643.
    32. Reuland SN, Goldstein NB, Partyka KA, Smith S, Luo Y, Fujita M, Gonzalez R, Lewis K, Norris DA, Shellman YG. ABT-737 synergizes with Bortezomib to kill melanoma cells. Biol Open. 2012 Feb 15; 1(2):92-100. PMID: 23213401; PMCID: PMC3507205.
    33. Reuland SN, Goldstein NB, Partyka KA, Cooper DA, Fujita M, Norris DA, Shellman YG. The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53. PLoS One. 2011; 6(8):e24294. PMID: 21897876; PMCID: PMC3163662.
    34. Luo Y, Robinson S, Fujita J, Siconolfi L, Magidson J, Edwards CK, Wassmann K, Storm K, Norris DA, Bankaitis-Davis D, Robinson WA, Fujita M. Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma. PLoS One. 2011; 6(6):e20971. PMID: 21698244; PMCID: PMC3115966.
    35. Tanaka A, Jensen JD, Prado R, Riemann H, Shellman YG, Norris DA, Chin L, Yee C, Fujita M. Whole recombinant yeast vaccine induces antitumor immunity and improves survival in a genetically engineered mouse model of melanoma. Gene Ther. 2011 Aug; 18(8):827-34. PMID: 21390072; PMCID: PMC4596232.
    36. Anwar A, Norris DA, Fujita M. Ubiquitin proteasomal pathway mediated degradation of p53 in melanoma. Arch Biochem Biophys. 2011 Apr 15; 508(2):198-203. PMID: 21167122; PMCID: PMC3060965.
    37. Okamoto M, Liu W, Luo Y, Tanaka A, Cai X, Norris DA, Dinarello CA, Fujita M. Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J Biol Chem. 2010 Feb 26; 285(9):6477-88. PMID: 20038581; PMCID: PMC2825443.
    38. Birlea SA, Costin GE, Norris DA. New insights on therapy with vitamin D analogs targeting the intracellular pathways that control repigmentation in human vitiligo. Med Res Rev. 2009 May; 29(3):514-46. PMID: 19241402.
      View in: PubMed
    39. Miller LA, Goldstein NB, Johannes WU, Walton CH, Fujita M, Norris DA, Shellman YG. BH3 mimetic ABT-737 and a proteasome inhibitor synergistically kill melanomas through Noxa-dependent apoptosis. J Invest Dermatol. 2009 Apr; 129(4):964-71. PMID: 18987671.
      View in: PubMed
    40. Goldstein NB, Johannes WU, Gadeliya AV, Green MR, Fujita M, Norris DA, Shellman YG. Active N-Ras and B-Raf inhibit anoikis by downregulating Bim expression in melanocytic cells. J Invest Dermatol. 2009 Feb; 129(2):432-7. PMID: 18668139.
      View in: PubMed
    41. Anwar A, Gu M, Brady S, Qamar L, Behbakht K, Shellman YG, Agarwal R, Norris DA, Horwitz LD, Fujita M. Photoprotective effects of bucillamine against UV-induced damage in an SKH-1 hairless mouse model. Photochem Photobiol. 2008 Mar-Apr; 84(2):477-83. PMID: 18266821.
      View in: PubMed
    42. Shellman YG, Howe WR, Miller LA, Goldstein NB, Pacheco TR, Mahajan RL, LaRue SM, Norris DA. Hyperthermia induces endoplasmic reticulum-mediated apoptosis in melanoma and non-melanoma skin cancer cells. J Invest Dermatol. 2008 Apr; 128(4):949-56. PMID: 17989736.
      View in: PubMed
    43. Riemann H, Takao J, Shellman YG, Hines WA, Edwards CK, Franzusoff A, Norris DA, Fujita M. Generation of a prophylactic melanoma vaccine using whole recombinant yeast expressing MART-1. Exp Dermatol. 2007 Oct; 16(10):814-22. PMID: 17845213.
      View in: PubMed
    44. Shellman YG, Makela M, Norris DA. Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines. Melanoma Res. 2006 Jun; 16(3):207-11. PMID: 16718267.
      View in: PubMed
    45. Ruth MC, Xu Y, Maxwell IH, Ahn NG, Norris DA, Shellman YG. RhoC promotes human melanoma invasion in a PI3K/Akt-dependent pathway. J Invest Dermatol. 2006 Apr; 126(4):862-8. PMID: 16470169.
      View in: PubMed
    46. Norris DA. Mechanisms of action of topical therapies and the rationale for combination therapy. J Am Acad Dermatol. 2005 Jul; 53(1 Suppl 1):S17-25. PMID: 15968260.
      View in: PubMed
    47. Shellman YG, Ribble D, Miller L, Gendall J, Vanbuskirk K, Kelly D, Norris DA, Dellavalle RP. Lovastatin-induced apoptosis in human melanoma cell lines. Melanoma Res. 2005 Apr; 15(2):83-9. PMID: 15846140.
      View in: PubMed
    48. Marr DG, Poser I, Shellman YG, Bosserhoff AK, Norris DA. Ultraviolet radiation induces release of MIA: a new mechanism for UVR-induced progression of melanoma. Int J Oncol. 2004 Jul; 25(1):105-11. PMID: 15201995.
      View in: PubMed
    49. Norris DA. How close are we to solving the puzzle? Review of the Alopecia Areata Research Workshop David Norris. J Investig Dermatol Symp Proc. 2003 Oct; 8(2):222-5. PMID: 14582679.
      View in: PubMed
    50. Shellman YG, Park YL, Marr DG, Casper K, Xu Y, Fujita M, Swerlick R, Norris DA. Release of vascular endothelial growth factor from a human melanoma cell line, WM35, is induced by hypoxia but not ultraviolet radiation and is potentiated by activated Ras mutation. J Invest Dermatol. 2003 Oct; 121(4):910-7. PMID: 14632212.
      View in: PubMed
    51. Duvic M, Norris D, Christiano A, Hordinsky M, Price V. Alopecia areata registry: an overview. J Investig Dermatol Symp Proc. 2003 Oct; 8(2):219-21. PMID: 14582678.
      View in: PubMed
    52. Urquhart JL, Meech SJ, Marr DG, Shellman YG, Duke RC, Norris DA. Regulation of Fas-mediated apoptosis by N-ras in melanoma. J Invest Dermatol. 2002 Sep; 119(3):556-61. PMID: 12230495.
      View in: PubMed
    53. Travers JB, Norris DA, Leung DY. The keratinocyte as a target for staphylococcal bacterial toxins. J Investig Dermatol Symp Proc. 2001 Dec; 6(3):225-30. PMID: 11924832.
      View in: PubMed
    54. Shellman YG, Chapman JT, Fujita M, Norris DA, Maxwell IH. Expression of activated N-ras in a primary melanoma cell line counteracts growth inhibition by transforming growth factor-beta. J Invest Dermatol. 2000 Jun; 114(6):1200-4. PMID: 10844567.
      View in: PubMed
    55. Pacheco TR, Maxwell F, Vasiloudes PE, Robinson WA, Norris DA, Maxwell IH. Positive tetracycline control of expression of p15INK4B from an Epstein-Barr autonomous plasmid in a human melanoma cell line. Gene. 2000 Jan 25; 242(1-2):249-56. PMID: 10721718.
      View in: PubMed
    56. Fujita M, Norris DA, Yagi H, Walsh P, Morelli JG, Weston WL, Terada N, Bennion SD, Robinson W, Lemon M, Maxwell IH, Yohn JJ. Overexpression of mutant ras in human melanoma increases invasiveness, proliferation and anchorage-independent growth in vitro and induces tumour formation and cachexia in vivo. Melanoma Res. 1999 Jun; 9(3):279-91. PMID: 10465584.
      View in: PubMed
    57. Norris DA, Whang K, David-Bajar K, Bennion SD. The influence of ultraviolet light on immunological cytotoxicity in the skin. Photochem Photobiol. 1997 Apr; 65(4):636-46. PMID: 9114739.
      View in: PubMed
    58. Norris DA, Middleton MH, Whang K, Schleicher M, McGovern T, Bennion SD, David-Bajar K, Davis D, Duke RC. Human keratinocytes maintain reversible anti-apoptotic defenses in vivo and in vitro. Apoptosis. 1997; 2(2):136-48. PMID: 14646548.
      View in: PubMed
    59. Seline PC, Norris DA, Horikawa T, Fujita M, Middleton MH, Morelli JG. Expression of E and P-cadherin by melanoma cells decreases in progressive melanomas and following ultraviolet radiation. J Invest Dermatol. 1996 Jun; 106(6):1320-4. PMID: 8752677.
      View in: PubMed
    60. Walsh P, Norris DA, Abe J, Martin DK, Giorno R, Leung DY. Candida albicans induces selective expansion of human T lymphocytes expressing the T-cell receptor variable region V beta 5.1. J Dermatol Sci. 1996 Jun; 12(2):140-6. PMID: 8814546.
      View in: PubMed
    61. Horikawa T, Norris DA, Zekman T, Morelli JG. Effective elimination of fibroblasts in cultures of melanocytes by lowering calcium concentration in TPA depleted medium following geneticin treatment. Pigment Cell Res. 1996 Apr; 9(2):58-62. PMID: 8857666.
      View in: PubMed
    62. Horikawa T, Norris DA, Johnson TW, Zekman T, Dunscomb N, Bennion SD, Jackson RL, Morelli JG. DOPA-negative melanocytes in the outer root sheath of human hair follicles express premelanosomal antigens but not a melanosomal antigen or the melanosome-associated glycoproteins tyrosinase, TRP-1, and TRP-2. J Invest Dermatol. 1996 Jan; 106(1):28-35. PMID: 8592077.
      View in: PubMed
    63. Norris DA, Duke R, Whang K, Middleton M. Immunologic cytotoxicity in alopecia areata: apoptosis of dermal papilla cells in alopecia areata. J Invest Dermatol. 1995 May; 104(5 Suppl):8S-9S. PMID: 7738399.
      View in: PubMed
    64. Middleton MH, Norris DA. Cytokine-induced ICAM-1 expression in human keratinocytes is highly variable in keratinocyte strains from different donors. J Invest Dermatol. 1995 Apr; 104(4):489-96. PMID: 7706764.
      View in: PubMed
    65. Horikawa T, Norris DA, Yohn JJ, Zekman T, Travers JB, Morelli JG. Melanocyte mitogens induce both melanocyte chemokinesis and chemotaxis. J Invest Dermatol. 1995 Feb; 104(2):256-9. PMID: 7530272.
      View in: PubMed
    66. Norris DA, Horikawa T, Morelli JG. Melanocyte destruction and repopulation in vitiligo. Pigment Cell Res. 1994 Aug; 7(4):193-203. PMID: 7855062.
      View in: PubMed
    67. Morelli JG, Yohn JJ, Zekman T, Norris DA. Melanocyte movement in vitro: role of matrix proteins and integrin receptors. J Invest Dermatol. 1993 Oct; 101(4):605-8. PMID: 8409531.
      View in: PubMed
    68. Morelli JG, Norris DA. Influence of inflammatory mediators and cytokines on human melanocyte function. J Invest Dermatol. 1993 Feb; 100(2 Suppl):191S-195S. PMID: 8381839.
      View in: PubMed
    69. Norris DA. Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol. 1993 Jan; 100(1):58S-68S. PMID: 8093710.
      View in: PubMed
    70. Brice SL, Stockert SS, Bunker JD, Bloomfield D, Huff JC, Norris DA, Weston WL. The herpes-specific immune response of individuals with herpes-associated erythema multiforme compared with that of individuals with recurrent herpes labialis. Arch Dermatol Res. 1993; 285(4):193-6. PMID: 8342962.
      View in: PubMed
    71. Yohn JJ, Morelli JG, Walchak SJ, Rundell KB, Norris DA, Zamora MR. Cultured human keratinocytes synthesize and secrete endothelin-1. J Invest Dermatol. 1993 Jan; 100(1):23-6. PMID: 8423387.
      View in: PubMed
    72. Yohn JJ, Lyons MB, Norris DA. Cultured human melanocytes from black and white donors have different sunlight and ultraviolet A radiation sensitivities. J Invest Dermatol. 1992 Oct; 99(4):454-9. PMID: 1402004.
      View in: PubMed
    73. Kashihara-Sawami M, Norris DA. The state of differentiation of cultured human keratinocytes determines the level of intercellular adhesion molecule-1 (ICAM-1) expression induced by gamma interferon. J Invest Dermatol. 1992 May; 98(5):741-7. PMID: 1373746.
      View in: PubMed
    74. Morelli JG, Kincannon J, Yohn JJ, Zekman T, Weston WL, Norris DA. Leukotriene C4 and TGF-alpha are stimulators of human melanocyte migration in vitro. J Invest Dermatol. 1992 Mar; 98(3):290-5. PMID: 1545138.
      View in: PubMed
    75. Morelli JG, Hake SS, Murphy RC, Norris DA. Leukotriene B4-induced human melanocyte pigmentation and leukotriene C4-induced human melanocyte growth are inhibited by different isoquinolinesulfonamides. J Invest Dermatol. 1992 Jan; 98(1):55-8. PMID: 1309461.
      View in: PubMed
    76. Yohn JJ, Norris DA, Yrastorza DG, Buno IJ, Leff JA, Hake SS, Repine JE. Disparate antioxidant enzyme activities in cultured human cutaneous fibroblasts, keratinocytes, and melanocytes. J Invest Dermatol. 1991 Sep; 97(3):405-9. PMID: 1875041.
      View in: PubMed
    77. Norris DA. Cytokine modulation of adhesion molecules in the regulation of immunologic cytotoxicity of epidermal targets. J Invest Dermatol. 1990 Dec; 95(6 Suppl):111S-120S. PMID: 2258627.
      View in: PubMed
    78. Yohn JJ, Critelli M, Lyons MB, Norris DA. Modulation of melanocyte intercellular adhesion molecule-1 by immune cytokines. J Invest Dermatol. 1990 Aug; 95(2):233-7. PMID: 1974278.
      View in: PubMed
    79. Morelli JG, Norris DA, Lyons MB, Murphy RC. Metabolism of exogenous leukotrienes by cultured human keratinocytes. J Invest Dermatol. 1990 May; 94(5):681-4. PMID: 2157767.
      View in: PubMed
    80. Furukawa F, Kashihara-Sawami M, Lyons MB, Norris DA. Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. J Invest Dermatol. 1990 Jan; 94(1):77-85. PMID: 2132545.
      View in: PubMed
    81. Morelli JG, Yohn JJ, Lyons MB, Murphy RC, Norris DA. Leukotrienes C4 and D4 as potent mitogens for cultured human neonatal melanocytes. J Invest Dermatol. 1989 Dec; 93(6):719-22. PMID: 2584737.
      View in: PubMed
    82. Furukawa F, Lyon MB, Norris DA. Susceptible cytotoxicity to ultraviolet B light in fibroblasts and keratinocytes cultured from autoimmune-prone MRL/Mp-lpr/lpr mice. Clin Immunol Immunopathol. 1989 Sep; 52(3):460-72. PMID: 2474396.
      View in: PubMed
    83. Lee LA, Gaither KK, Coulter SN, Norris DA, Harley JB. Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice. J Clin Invest. 1989 May; 83(5):1556-62. PMID: 2651477; PMCID: PMC303861.
    84. Norris DA, Huff JC, Weston WL. The state of research in cutaneous biology: a perspective in the 50th anniversary year of the Society for Investigative Dermatology and The Journal of Investigative Dermatology. J Invest Dermatol. 1989 Apr; 92(4 Suppl):179S-197S. PMID: 2649610.
      View in: PubMed
    85. Furukawa F, Lyons MB, Lee LA, Coulter SN, Norris DA. Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. Another possible mechanism for estradiol influence of lupus erythematosus. J Immunol. 1988 Sep 01; 141(5):1480-8. PMID: 2457617.
      View in: PubMed
    86. Norris DA, Kissinger RM, Naughton GM, Bystryn JC. Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. J Invest Dermatol. 1988 Jun; 90(6):783-9. PMID: 3373009.
      View in: PubMed
    87. Furukawa F, Huff JC, Lyons MB, Weston WL, Norris DA. Characterization and practical benefits of keratinocytes cultured in strontium-containing serum-free medium. J Invest Dermatol. 1988 May; 90(5):690-6. PMID: 2452209.
      View in: PubMed
    88. Brice SL, Norris DA, Weston WL, Tedder DG, Lyons MB, Furukawa F, Huff JC. Development of an in vitro keratinocyte model for use in the study of HSV specific cytotoxicity. J Invest Dermatol. 1988 May; 90(5):629-33. PMID: 2452207.
      View in: PubMed
    89. Jones SK, Coulter S, Harmon C, Norris DA, Rosandich M, Lee LA. Ro/SSA antigen in human epidermis. Br J Dermatol. 1988 Mar; 118(3):363-7. PMID: 3258526.
      View in: PubMed
    90. Furukawa F, Huff JC, Weston WL, Norris DA. Serum-free serial culture of adult human keratinocytes from suction-blister roof epidermis. J Invest Dermatol. 1987 Nov; 89(5):460-3. PMID: 3668291.
      View in: PubMed
    91. Norris DA, Lee LA. Pathogenesis of cutaneous lupus erythematosus. Clin Dermatol. 1985 Jul-Sep; 3(3):20-35. PMID: 2463862.
      View in: PubMed
    Norris's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)